Canada’s free ride on U.S. drug development may end soon
A shift in U.S. drug pricing could cut pharmaceutical profits, meaning less money for research and development
Read MorePosted by Steven Globerman | Dec 6, 2018
A shift in U.S. drug pricing could cut pharmaceutical profits, meaning less money for research and development
Read MorePosted by Bacchus Barua | Oct 18, 2018
Instead of using scarce health-care dollars broadly, we should identify and support those Canadians falling through the cracks
Read MorePosted by Bacchus Barua | Jun 15, 2018
Our closed government-heavy system stands in stark contrast to other universal health-care systems that have shorter wait times
Read MorePosted by Bacchus Barua | May 15, 2018
We’ve seen decades of policy paralysis, with provinces constantly under threat of penalty for exploring policy options
Read MorePosted by Bacchus Barua | May 3, 2018
We should stop demonizing private clinics – and the patients who need them – and recognize that they’re part of the solution
Read More